Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

International Parkinson and Movement Disorder Society
Main Content

67yo man with new onset myoclonic jerks

Summary of observations:

67yo man with past medical history significant for coronary artery disease and insulin-dependent diabetes who presented to the emergency department at Ne wYork Presbyterian in mid-April 2020 with abnormal movements that appeared myoclonic as well as movements that appeared to be characterized by a loss of tone, or a "negative myoclonus". These movements were interfering with his activities of daily life which is why he presented to the hospital. Also was found with a new head tremor and difficulty with swallowing. Was found to be SARS-CoV2 positive via PCR testing on admission. Had elevated glucose levels to 300's on admission and he also admitted he as having trouble adhering to his insulin regimen at home. Was started on levetiracetam in the hospital which resolved his myoclonic jerks and dysphagia. Patient never developed respiratory distress, renal dysfunction or cardiac dysfunction associated with severe COVID. Was discharged from hospital following improvement of movement disorder with levetiracetam with plans for outpatient follow-up in our movement disorders clinic.

The following required items were not provided or are in the wrong format. Please provide the required responses and submit again:

Comment Title
Comment: 1000 characters
  [[put error message here]]


We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice